DESCRIPTION The total number of people worldwide with diabetes mellitus is projected to rise from 171 million in 2000 to 366 million in 2030. In the United States, almost 24 million or 8 percent of the population has diabetes mellitus. Approximately 4.0 million Americans age 40 and older have diabetic retinopathy, 900,000 of whom have vision threatening disease, defined as pre-proliferative retinopathy, macular edema, or both. Diabetic retinopathy remains the leading cause of blindness in ad...

Alexander Brucker, MD, is professor of ophthalmology at the University of Pennsylvania, and chief, Retina-Vitreous Services at Philadelphia's Scheie Eye Institute. George L. Mayo, MD, is a clinical instructor at the Scheie Eye Institute and a fellow in vitreoretinal surgery at the University of Pennsylvania School of Medicine. Here, they define diabetic retinopathy, describe the retina and its function, and discuss diagnosis, and treatment of this leading cause of blindness in the age group 20...

Medications for glaucoma can increase the risk of ocular surface disease in an already susceptible population. In addition to the active ingredient, preservatives in these medications may exacerbate ocular surface disease. In this monograph, leading clinicians review preservatives in glaucoma medications and differences in their effects on the ocular surface. The importance of screening patients with glaucoma for ocular surface disease will be presented along with optimal diagnostic tests. Str...

Glaucoma is a major public health concern. More than 2 million U.S. adults are currently affected, and that number is expected to increase by 50% or more by the year 2020. Nearly half are unaware of their glaucoma and do not receive treatment. Each year, there are more than 7 million office visits related to screening, evaluation, and management of glaucoma. Glaucoma is a significant component of most comprehensive ophthalmology practices. Since patients experience no symptoms in the early sta...

Medications and surgical interventions are both effective options for treating glaucoma. In the United States, physicians and patients usually choose medication as the initial treatment. In this issue, glaucoma experts discuss choices for initial and adjunctive medical therapy in glaucoma, as well as pros and cons of using generic medications.

Glaucoma is a significant component of most comprehensive ophthalmology practices. Since patients experience no symptoms in the early stages, ophthalmologists must screen patients for undetected glaucomatous optic neuropathy. This issue is devoted to management of patients with narrow or closed angles. International experts discuss the different presentations of glaucoma, especially in different Asian ethnic groups, screening with gonioscopy and anterior segment imaging and surgical procedures...

Ocular surface disease (OSD) is a well-established comorbid condition in patients with ocular hypertension and glaucoma. Like glaucoma, its incidence increases with age. Long-term IOP reduction with topical antiglaucoma pharmacotherapy is a serious challenge in this affected population - whether due to OSD or the medication. Faculty will engage learners in an evidence-based interactive expert panel discussion that will analyze the scope of the problem, identify modifiable risk factors which im...

Overview CME certified newsletters and podcasts Concise reviews of important journal literature and corresponding case based podcast discussions Provided completely without charge or prerequisites Delivered directly to your email inbox Program Learning Objectives: After participating in this activity, the participant will demonstrate the ability to: Evaluate corticosteroids and anti-VEGF drugs alone or in combination with laser therapy for the treatment of diabetic retinopathy Desc...

OVERVIEW Ocular surface diseases are important public health issues that have negative impacts on the quality of life and productivity of patients. Because they are more common in older females and perceived as female diseases, patients from different demographics are frequently underdiagnosed. Furthermore, statistics conclude that eye care professionals underappreciate the impact of ocular surface diseases on patients’ quality of life and productivity and do not appear to fully recogniz...

HIGHLIGHTS Cataract surgery pearls for your practice New approaches in maintaining and restoring a healthy ocular surface How to manage corneal problems in your office Novel therapeutics in glaucoma Retina management for the comprehensive ophthalmologist Breakfast roundtable discussions: Meet the experts Best of UC Davis Grand Rounds Ethics - fulfills the 3 hour requirement for Maintenance of Certification Mini - symposia: • Optimizing your ophthalmic practice • The Electron...

SEPTEMBER 7, 2012 Bradley R. Williams, Pharm.D, FASCP, CGP University of Southern California and serves on the Board of Directors for the ASCP. GERIATRICS: EVALUATING THE GERIATRIC PATIENT, INCONTINENCE, AND GI DISORDERS ACPE # 043-999-10-030-L01-P Objectives: 1. Describe the characteristics of a successful interview to obtain and record pertinent health information. 2. Recognize medications that are potentially inappropriate for older adults and list therapeutic alternati...

Eye inflammation involves the abnormal swelling of any ocular tissues. The condition can be the result of an exogenous insult, either iatrogenic or accidental, in addition to an endogenous source such as an autoimmune disease or pathogen. These insults cause disruption of the blood barrier and cellular infiltration, leading to intraocular inflammation. Two common causes of ocular inflammation are uveitis and cataract surgery. Uveitis is inflammation that occurs in the uveal tract of the ey...